National Screening Service says accreditation issues of cervical cancer screening lab have been resolved
The quality and safety of the lab service 'was not in question' during the suspension of work at the lab, according to Fiona Murphy, chief executive of the National Screening Service. Photograph: Getty Images
The quality and safety of the lab service “was not in question” during the suspension of work at the lab, Ms Murphy stressed. Its INAB accreditation was then suspended for HPV and cytology sample processing pending the completion of this process. Last year, public health expert Dr Gabriel Scally, who investigated the 2018 controversy over CervicalCheck, highlighted a range of issues he said needed to be resolved before screening could resume. These included the level of staffing and, in particularly, the lack of a person qualified to act as lead pathologist.